NEW YORK, Feb. 29, 2024 /PRNewswire/ -- AI pioneer Aidoc and the American College of Cardiology (ACC) are collaborating to revolutionize cardiovascular care through industry-leading artificial intelligence (AI) technology. This collaboration will drive enhanced outcomes for patients with incidentally identified coronary artery calcification (CAC) by ensuring that all patients receive the most effective follow-up and ACC guideline-concordant treatment.
Under the collaboration, ACC will review Aidoc's AI technology to enhance the identification of patients with CAC, a critical precursor to cardiovascular diseases such as heart attack and stroke. Aidoc's FDA-cleared proprietary technology communicates findings to radiologists and enables coordinated, automatic patient follow-up care.
For example, if a patient presents at the Emergency Department (ED) following a car accident and undergoes a CT scan to check for injuries, Aidoc's image-based AI will apply all available algorithms based on visible anatomy and identify and document potential CAC directly into the radiology report, even when the scan's primary purpose is unrelated to cardiovascular concerns. After the confirmed documentation, Aidoc's ambulatory patient management platform will identify every patient with a mention of CAC and help health systems identify healthy patients with increased risk of cardiovascular disease who are not already under active management.
Ad Statistics
Times Displayed: 174441
Times Visited: 3180 For those who need to move fast and expand clinical capabilities -- and would love new equipment -- the uCT 550 Advance offers a new fully configured 80-slice CT in up to 2 weeks with routine maintenance and parts and Software Upgrades for Life™ included.
"Our collaboration with Aidoc is aligned with the ACC's mission to transform cardiovascular care and improve heart health for all," stated Ami Bhatt, MD, Chief Innovation Officer, American College of Cardiology. "These advanced tools that identify coronary artery calcium and communicate potential increased cardiovascular risk are an important advancement in population health."
Together, the organizations will be collaborating on three primary focuses:
Refining Aidoc's Solution: Aidoc and ACC will work together to enhance Aidoc's AI-enabled solution, ensuring seamless engagement of clinical teams, guideline-directed medical therapy (GDMT), and recommended follow-up. Areas where the organizations will focus on co-development include care pathways, notification methods, ambulatory medicine engagement, provider feedback loops, and patient-centric communication.
Integration of ACC Guidelines: ACC's Clinical Guidelines for Prevention and Coronary Artery Disease will be integrated into Aidoc's solution to enhance workflows for clinical teams. These guidelines will serve as the foundation for developing upstream workflows and assisting clinical teams in effectively utilizing Aidoc's solution.
